Summary
The monitoring of quinine by HPLC in 3 patients suffering from cerebral malaria with acute renal failure and treated by haemofiltration is reported.
The recommended dose of quinine in this situation is reduced to 10 to 15 mg·kg−1·day−1. However, in the first patient, when given quinine 10 mg kg−1·day−1 the plasma concentration was mainly below the recommended therapeutic range of 5 to 15 mg/l. In consequence, the dose of quinine in the second patient was elevated to quinine dihydrochloride 15.1 mg·kg−1·day−1 which produced plasma concentrations in the low therapeutic range. In the third patient, an unreduced dose of quinine dihydrochloride 25.7 mg·kg−1·day−1 was employed, resulting in plasma concentrations above 15 mg/l, which is generally assumed to be toxic, although, no sign of acute quinine toxicity was seen.
The antimalarial effect in all three patients was satisfactory. Quinine was estimated in the haemofiltrate in two patients and was found to be below the limit of sensitivity (0.25 mg/l). Plasma quinine did not change during or shortly after haemofiltration.
It is concluded that in case of acute renal failure in cerebral malaria the dose of quinine should be reduced, but that the common recommendation of 10 to 15 mg·kg−1·day−1 may be too low, and that haemofiltration has no marked influence on the total body clearance of quinine.
Similar content being viewed by others
References
Hall AP (1976) The treatment of malaria. Br Med J 1: 323–328
Miller L (1983) Malaria. In: Hoeprich P (ed) Infectious diseases. Harper and Row, Philadelphia
Wolfe M (1979) Antiparasitic agents. In: Mandell G, Douglas RG, Bennett JE (eds) Principles and practice of infectious diseases. Wiley & Sons, New York
Severe and complicated malaria. World health organization malaria action programme (1986). Trans Roy Soc Trop Med Hyg 80 [Suppl]: 20–24
Hofheinz W, Merkli B (1984) Quinine and quinine analogues. In: Peters W, Richards WHG (eds) Antimalarial drugs II. Springer, Berlin Heidelberg New York
Stone WJ, Hanchett JE, Knepshield JH (1972) Acute renal insufficiency due to falciparum malaria. Arch Int Med 129: 620–628
Donadio J, Whelton A, Kazyak L (1968) Quinine therapy and peritoneal dialysis in acute renal failure complicating malarial haemoglobinuria. Lancet 1: 375–379
Hall AP, Yardumian A, Marsh A (1985) Exchange transfusion and quinine concentrations in falciparum malaria. Lancet 2: 1169–1170
Johnston MA, Smith WJ, Kennedy JM, Lea AR, Hailay DM (1980) Reversed-phase high-performance liquid chromatographic analysis of cinchona alkaloids in pharmaceuticals. J Chromatogr 189: 241–247
Edstein M, Stace J, Shann F (1983) Quantification of quinine in human serum by high-performance liquid chromatography. J Chromatogr 278: 445–451
Tett SE, Cutler DJ, Brown KF (1985) High-performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma. J Chromatogr 344: 241–248
Hall AP (1985) Dangers of high-dose quinine and overhydration in severe malaria. Lancet 1: 1453–1454
Gibbs JL, Trafford A, Sharpstone P (1985) Quinine amblyopia treated by combined haemodialysis and activated resin haemoperfusion. Lancet 1: 752–753
Boland ME, Brenard Roper SM, Henry JA (1985) Complications of quinine poisoning. Lancet 1: 384–385
Bateman DN, Blain PG, Woodhouse KW, Rawlins MD, Dyson EH, Heyworth R, Prescott LF, Proudfoot AT (1985) Pharmacokinetics and clinical toxicity of quinine overdosage: Lack of efficacy of techniques intended to enhance elimination. Q J Med 54: 125–131
Dyson EH, Proudfoot AT, Prescott LF, Heyworth R (1985) Death and blindness due to overdose of quinine. Br Med J 291: 31–33
White NJ, Looareesuwan S, Warrel DA, Warrel MJ, Bunnag D, Harinasuta T (1982) Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 73: 564–572
Silamut K, White NJ, Looareesuwan S, Warrell DA (1985) Binding of quinine to plasma proteins in falciparum malaria. J Trop Med Hyg 34: 681–686
Weise M, Ehrich JHH, Voller A (1976) Nierenbeteiligung bei Malaria. Klin Wochenschr 54: 651–660
Sitprija V, Indraprasit S, Pochanugool C, Benyajati C, Piyaratn P (1967) Renal failure in malaria. Lancet 1: 185–188
Reid HA, Goldsmith HJ, Wright FK (1967) Peritoneal dialysis in acute renal failure following malaria. Lancet 2: 436–439
Canfield CJ, Miller LH, Bartelloni PJ, Eichler P, Berry KG (1968) Acute renal failure in plasmodium falciparum malaria. Arch Int Med 122: 199–203
Clyde DF (1986) Malaria. In: Braude AI, Davis CE, Fierer J (eds) Infectious diseases and medical microbiology. WB Saunders, Philadelphia
Rollo I (1980) Drugs used in the chemotherapy of malaria. In: Goodman Gilman A, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York
Dukes DC, Sealey BJ, Forbes JI (1968) Oliguric renal failure in blackwater fever. Am J Med 45: 899–903
Sabto J, Pierce RM, West RH, Gurr FW (1981) Hemodialysis, peritoneal dialysis, plasmapheresis and forced diuresis for the treatment of quinine overdose. Clin Nephrol 16: 264–268
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Franke, U., Proksch, B., Müller, M. et al. Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated by haemofiltration. Eur J Clin Pharmacol 33, 293–296 (1987). https://doi.org/10.1007/BF00637565
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637565